Is There Life After COMBACTE?
Much is being invested in the establishment of CLIN-Net and LAB-Net. Wouldn’t it be a shame if European society ceases to benefit from this after 2021? The answer is obvious. This story is about looking at the future and a fruitful cooperation. Prof. Dr. Marc Bonten (Scientific Coordinator COMBACTE) and Prof. Herman Goossens (Academic Lead COMBACTE-NET and LAB-Net, and Coordinator for PREPARE) share their views on the future existence of an active European network for clinical trials in infectious diseases: ECRAID.
ECRAID Piece
Related updates
Webinar Combatting Antimicrobial Resistance: The Legacy of the IMI COMBACTE Projects
On May 31st, the Innovative Health Initiative will host an Impact Webinar spotlighting the significant outcomes of the COMBACTE projects in combating ...
“We Take Bigger Steps Together”
